A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27103162)

Published in BMC Res Notes on April 22, 2016

Authors

Kamini E Kuchinad1, Heidi E Hutton2, Anne K Monroe2, Garrick Anderson3, Richard D Moore2, Geetanjali Chander2

Author Affiliations

1: Department of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA. Kkuchin1@jhmi.edu.
2: Department of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
3: University of Maryland School of Medicine, Baltimore, MD, USA.

Articles cited by this

Qualitative research: standards, challenges, and guidelines. Lancet (2001) 15.85

Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS (2008) 9.10

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57

How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) (2001) 6.00

Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (2005) 5.43

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction (2002) 5.07

Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60

Qualitative and mixed methods provide unique contributions to outcomes research. Circulation (2009) 4.28

Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med (2004) 4.17

Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction (2008) 3.98

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (2001) 3.56

Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS (2006) 3.02

Patient-doctor communication. Med Clin North Am (2003) 2.99

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol (2006) 2.81

Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med (2015) 2.80

Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis (2012) 2.70

The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med (2009) 2.61

Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav (2008) 2.49

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction (2008) 2.46

Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr (2008) 2.36

Standards for reporting qualitative research: a synthesis of recommendations. Acad Med (2014) 2.35

Health psychology: psychological adjustment to chronic disease. Annu Rev Psychol (2007) 2.03

Breaking bad news about cancer: patients' preferences for communication. J Clin Oncol (2001) 2.00

Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care (2003) 1.78

Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review. J Int AIDS Soc (2014) 1.78

Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol (2003) 1.58

Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS (2009) 1.56

Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (2013) 1.49

Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One (2009) 1.48

Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. J Int AIDS Soc (2012) 1.44

A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37

Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr (2006) 1.35

Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis (2004) 1.33

Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. J Gen Intern Med (2012) 1.33

Rethinking confrontation in alcohol and drug treatment: consideration of the clinical context. Subst Use Misuse (2003) 1.30

The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff (Millwood) (2011) 1.29

"Taking a half day at a time:" patient perspectives and the HIV engagement in care continuum. AIDS Patient Care STDS (2013) 1.27

Illicit drug use and HIV treatment outcomes in a US cohort. AIDS (2008) 1.24

Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Soc Sci Med (2005) 1.21

Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav (2005) 1.14

Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS (2010) 1.12

Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS One (2011) 1.10

Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav (2013) 1.09

The doctor-patient relationship and HIV-infected patients' satisfaction with primary care physicians. J Gen Intern Med (2000) 1.00

Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study. Clin Infect Dis (2004) 1.00

Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008. Clin Infect Dis (2010) 0.98

Prevention and treatment of HIV/AIDS among drug-using populations: a global perspective. J Acquir Immune Defic Syndr (2010) 0.90

Qualitative research and the epidemiological imagination: a vital relationship. Gac Sanit (2003) 0.86

HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment. AIDS Patient Care STDS (2014) 0.82

Disclosing the cancer diagnosis: the patients' experiences. Eur J Cancer (1997) 0.80

A multilevel mediation model of stress and coping for women with HIV and their families. Fam Process (2010) 0.76